Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain-Reference-Cited by-同舟云学术

Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain

Published:2018-05 Issue:4 Volume:28 Page:258-265
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Vandenberghe Frederik¹,Najar-Giroud Alexandra²,Holzer Laurent³,Conus Philippe⁴,Eap Chin B.¹⁵,Ambresin Anne-Emmanuelle²

Affiliation:

1. Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital, Hospital of Cery, Prilly, Switzerland.

2. Interdisciplinary Division for Adolescent Health (DISA), Lausanne University Hospital, Lausanne, Switzerland.

3. Department of Psychiatry, Child and Adolescent Psychiatric Clinic, Lausanne University Hospital, Lausanne, Switzerland.

4. Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Hospital of Cery, Prilly, Switzerland.

5. Department of Pharmaceutical Sciences, School of Pharmacy, University of Geneva, University of Lausanne, Geneva, Switzerland.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2017.0038

Reference38 articles.

1. Childhood and Adolescent Depression: A Review of the Past 10 Years. Part I

2. Children with Type 2 Diabetes Mellitus and the Prevalence of Psychiatric Disorders

3. Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?

4. Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort;European Psychiatry;2022

2. Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia;European Psychiatry;2022

3. Six months functional response to early psychosis intervention program best predicts outcome after three years;Schizophrenia Research;2021-12

4. Current strategies for predicting side effects from second generation antipsychotics in youth;Expert Opinion on Drug Metabolism & Toxicology;2021-05-02